» Articles » PMID: 17587821

Transforming Growth Factor-beta and MicroRNA:mRNA Regulatory Networks in Epithelial Plasticity

Overview
Publisher Karger
Date 2007 Jun 26
PMID 17587821
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Noncoding microRNAs act as posttranscriptional repressors of gene function and are often deregulated in cancers and other diseases. Here we review recent findings on microRNA roles in tumorigenesis and report a microRNA profiling screen in transforming growth factor-beta1 (TGF-beta)-induced epithelial-mesenchymal transition (EMT) in human keratinocytes, a model of epithelial cell plasticity underlying epidermal injury and skin carcinogenesis. We describe a novel EMT-specific microRNA signature that includes induction of miR-21, a candidate oncogenic microRNA associated with carcinogenesis. By integrating the microRNA screen results with target prediction algorithms and gene expression profiling data, we outline a framework for TGF-beta-directed microRNA:messenger RNA (mRNA) regulatory circuitry and discuss its biological relevance for tumor progression.

Citing Articles

Psoriasis Treatments: Emerging Roles and Future Prospects of MicroRNAs.

Teo L, Juantuah-Kusi N, Subramanian G, Sampath P Noncoding RNA. 2025; 11(1).

PMID: 39997616 PMC: 11858470. DOI: 10.3390/ncrna11010016.


Melatonin and Its Role in the Epithelial-to-Mesenchymal Transition (EMT) in Cancer.

Martinez-Campa C, Alvarez-Garcia V, Alonso-Gonzalez C, Gonzalez A, Cos S Cancers (Basel). 2024; 16(5).

PMID: 38473317 PMC: 10931174. DOI: 10.3390/cancers16050956.


Role of Cyclins and Cytoskeletal Proteins in Endometriosis: Insights into Pathophysiology.

Szymanski M, Bonowicz K, Antosik P, Jerka D, Glowacka M, Soroka M Cancers (Basel). 2024; 16(4).

PMID: 38398227 PMC: 10886501. DOI: 10.3390/cancers16040836.


Epithelial-Mesenchymal Transition: A Fundamental Cellular and Microenvironmental Process in Benign and Malignant Prostate Pathologies.

Goncharov A, Vashakidze N, Kharaishvili G Biomedicines. 2024; 12(2).

PMID: 38398019 PMC: 10886988. DOI: 10.3390/biomedicines12020418.


Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies.

Pouliquen D, Boissard A, Henry C, Coqueret O, Guette C Front Pharmacol. 2022; 13:934534.

PMID: 35873564 PMC: 9304619. DOI: 10.3389/fphar.2022.934534.